INDIANAPOLIS — At least 26 patients have filed lawsuits in Marion County against Eli Lilly and Co., alleging the pharmaceutical giant failed to adequately warn consumers about severe side effects linked to its GLP-1 medications Trulicity and Mounjaro.
The suits, filed in Marion Superior Court over the past two weeks, claim the Indianapolis-based company downplayed or omitted critical information regarding the risks associated with the diabetes and weight-loss drugs. Seventeen of the lawsuits also name Novo Nordisk Inc. as a co-defendant, making similar allegations about its GLP-1 drug Ozempic.
According to court documents, the patients allege the drugs caused serious gastrointestinal complications, including gastroparesis, persistent vomiting and dehydration, severe diarrhea and constipation, and, in some cases, multiple hospitalizations. While both drugmakers have acknowledged the potential for gastrointestinal side effects, the lawsuits argue that the companies understated the severity, duration, and scope of those effects and failed to disclose other potential risks…